New drug painted on tumors during surgery to fight breast cancer
NCT ID NCT06300411
Summary
This early-stage study is testing a new drug called SRG-514. It is applied directly to the surgical site right after a breast tumor is removed, aiming to help control the cancer. The main goal is to find a safe and effective dose by testing it in a small group of patients. Researchers will closely monitor for side effects and how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Audie Murphy VA
San Antonio, Texas, 78229, United States
-
Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo
Rochester, Minnesota, 55905, United States
-
Memorial Health
Savannah, Georgia, 31404, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.